Please use this identifier to cite or link to this item:
Type: Outro documento
Title: Authors’ reply – comments: Serum levels of infliximab in Brazilian patients with crohn’s disease: what are the reasons for differences from previous studies?
Author: Gomes, L.E.M.
da Silva, F.A.R.
Pascoal, L.B.
Ricci, R.L.
Nogueira, G.
Camargo, M.G.
Ayrizono, M.L.S.
Fagundes, J.J.
Leal, R.F.
Abstract: sem informação
Subject: Infliximab
Country: Brasil
Editor: USP
Rights: Aberto
Identifier DOI: 10.6061/clinics/2019/e1517
Date Issue: 2019
Appears in Collections:FCM - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
S1807-59322019000100405.pdf214.39 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.